HIKMA PHARMACEUTIC.LS-,10/ GB00B0LCW083 /
2024-08-28 10:59:26 PM | Chg. -0.200 | Volume | Bid10:59:26 PM | Ask10:59:26 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
23.600EUR | -0.84% | - Turnover: - |
23.600Bid Size: - | 23.800Ask Size: - | 5.22 bill.EUR | - | - |
Assets
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 507 | 969 | 828 | 870 | 912 | ||||||
Intangible Assets | 607 | 1,037 | 503 | 487 | 552 | ||||||
Long-Term Investments | 53 | 55 | 66 | 68 | 43 | ||||||
Fixed Assets | 1,237 | 2,915 | 1,814 | 1,829 | 2,082 | ||||||
Inventories | 251 | 459 | 488 | 528 | 568 | ||||||
Accounts Receivable | 488 | 759 | 707 | 731 | 719 | ||||||
Cash and Cash Equivalents | 553 | 155 | 227 | 276 | 442 | ||||||
Current Assets | 1,360 | 1,448 | 1,574 | 1,668 | 1,848 | ||||||
Total Assets | 2,597 | 4,363 | 3,388 | 3,497 | 3,930 |
Liabilities
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 276 | 343 | 365 | 465 | 473 | ||||||
Long-term debt | 590 | 721 | 670 | 539 | 48 | ||||||
Liabilities to Banks | 705 | 838 | 756 | 613 | 617 | ||||||
Provisions | 49 | 42 | 75 | 39 | 43 | ||||||
Liabilities | 1,245 | 1,952 | 1,860 | 1,800 | 1,801 | ||||||
Share Capital | 35.2000 | 40 | 40 | 40 | 41 | ||||||
Total Equity | 1,337 | 2,396 | 1,514 | 1,685 | 2,117 | ||||||
Minority Interests | 15 | 15 | 14 | 12 | 12 | ||||||
Total liabilities equity | 2,597 | 4,363 | 3,388 | 3,497 | 3,930 |
Income Statement
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,440 | 1,950 | 1,936 | 2,070 | 2,207 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 381 | 302 | -747 | 371 | 493 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | 318 | 210 | -738 | 293 | 491 | ||||||
Income Taxes | -64 | -52 | -101 | -8 | -4 | ||||||
Minority Interests Profit | -2 | -3 | -4 | -4 | -1 | ||||||
Net Income | 252 | 155 | -843 | 282 | 486 |
Per Share
Cash Flow
2015 IFRS in mill. USD |
2016 IFRS in mill. USD |
2017 IFRS in mill. USD |
2018 IFRS in mill. USD |
2019 IFRS in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 366 | 293 | 443 | 430 | 472 | ||||||
Cash Flow from Investing Activities | -162 | -695 | -151 | -96 | -151 | ||||||
Cash Flow from Financing | 77 | 19 | -220 | -278 | -155 | ||||||
Decrease / Increase in Cash | 281 | -383 | 72 | 56 | 166 | ||||||
Employees | 7,189 | 8,339 | 8,521 | 8,413 | 8,578 |